Unicorn Medident Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 18-07-2024
- Paid Up Capital ₹ 2.50 M
as on 18-07-2024
- Company Age 27 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.95 Cr
as on 18-07-2024
- Satisfied Charges ₹ 31.04 Cr
as on 18-07-2024
- Revenue 74.83%
(FY 2023)
- Profit 40.56%
(FY 2023)
- Ebitda 51.50%
(FY 2023)
- Net Worth 14.07%
(FY 2023)
- Total Assets 28.85%
(FY 2023)
About Unicorn Medident
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹50.95 Cr. The company has closed loans amounting to ₹31.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shammi Gumbhir and Achla Gumbhir serve as directors at the Company.
- CIN/LLPIN
U33111DL1997PTC091175
- Company No.
091175
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Unicorn Medident?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shammi Gumbhir  | Managing Director | 15-Dec-1997 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Achla Gumbhir | Director | 15-Dec-1997 | Current |
Financial Performance of Unicorn Medident.
Unicorn Medident Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 74.83% increase. The company also saw a substantial improvement in profitability, with a 40.56% increase in profit. The company's net worth Soared by an impressive increase of 14.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unicorn Medident?
In 2023, Unicorn Medident had a promoter holding of 99.92% and a public holding of 0.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Dec 2023 | ₹3.00 Cr | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 31 May 2022 | ₹4.95 Cr | Open |
Axis Bank Limited Creation Date: 28 Oct 2021 | ₹17.00 Cr | Open |
How Many Employees Work at Unicorn Medident?
Unicorn Medident has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unicorn Medident, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unicorn Medident's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
